SVB Wealth LLC acquired a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 55,886 shares of the medical research company's stock, valued at approximately $7,508,000.
Other institutional investors have also added to or reduced their stakes in the company. Flynn Zito Capital Management LLC boosted its holdings in shares of Agilent Technologies by 3.8% in the 4th quarter. Flynn Zito Capital Management LLC now owns 1,871 shares of the medical research company's stock worth $251,000 after buying an additional 69 shares during the last quarter. IFP Advisors Inc boosted its stake in Agilent Technologies by 17.7% in the fourth quarter. IFP Advisors Inc now owns 458 shares of the medical research company's stock valued at $62,000 after acquiring an additional 69 shares during the last quarter. Brown Brothers Harriman & Co. grew its position in shares of Agilent Technologies by 13.5% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 646 shares of the medical research company's stock valued at $96,000 after acquiring an additional 77 shares during the period. Rothschild Investment LLC increased its stake in shares of Agilent Technologies by 19.2% during the 4th quarter. Rothschild Investment LLC now owns 491 shares of the medical research company's stock worth $66,000 after purchasing an additional 79 shares during the last quarter. Finally, Rovin Capital UT ADV increased its stake in shares of Agilent Technologies by 1.6% during the 3rd quarter. Rovin Capital UT ADV now owns 5,049 shares of the medical research company's stock worth $750,000 after purchasing an additional 81 shares during the last quarter.
Wall Street Analysts Forecast Growth
Several research firms have commented on A. Wells Fargo & Company dropped their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating on the stock in a report on Monday, December 9th. Sanford C. Bernstein dropped their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating on the stock in a research note on Tuesday, November 26th. Robert W. Baird reduced their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research note on Thursday, February 27th. Citigroup increased their target price on Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research report on Thursday, December 19th. Finally, StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Tuesday, December 24th. Seven research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $146.15.
Get Our Latest Stock Report on A
Insider Buying and Selling
In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the company's stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. This represents a 4.60 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
Agilent Technologies Price Performance
Shares of A stock traded down $3.25 during trading on Tuesday, hitting $123.08. The company had a trading volume of 1,877,977 shares, compared to its average volume of 1,762,854. The stock's 50-day moving average is $140.48 and its two-hundred day moving average is $139.08. The stock has a market capitalization of $35.11 billion, a price-to-earnings ratio of 28.32, a price-to-earnings-growth ratio of 3.59 and a beta of 1.11. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. Agilent Technologies, Inc. has a 52 week low of $121.45 and a 52 week high of $155.35.
Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The firm had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. As a group, analysts predict that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.
Agilent Technologies Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.81%. Agilent Technologies's dividend payout ratio is 22.76%.
Agilent Technologies Profile
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Further Reading
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
